Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Bifidobacterium animalis subsp. lactis Bi-07 is a clinically studied probiotic strain that produces short-chain fatty acids, particularly acetate and lactate, which strengthen intestinal barrier function. This strain enhances digestive health by increasing beneficial bacterial populations and modulating immune responses through interaction with intestinal epithelial cells.
Reported Benefits (Provisional)
Origin & History
Bifidobacterium animalis subsp. lactis Bi-07 is a probiotic strain derived from the gut microbiota of healthy individuals. It is known for its resilience and ability to thrive in the digestive tract.
Research Narrative (Provisional)
Research supports its role in improving digestive health and boosting immunity, though further studies are needed to confirm other health claims.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Reported Mechanism (Provisional)
Bi-07 adheres to intestinal epithelial cells via specific adhesins, producing acetate and lactate that lower colonic pH and inhibit pathogenic bacteria growth. The strain stimulates dendritic cells and enhances secretory IgA production through toll-like receptor signaling pathways. It strengthens tight junction proteins like claudin-1 and occludin, improving intestinal barrier integrity.
Clinical Narrative (Provisional)
Human clinical trials with sample sizes ranging from 60-200 participants demonstrate Bi-07's efficacy in reducing constipation by 40% and decreasing upper respiratory tract infections by 27%. Double-blind, placebo-controlled studies show significant improvements in stool frequency and consistency within 2-4 weeks at doses of 1-10 billion CFU daily. Evidence quality is moderate with most studies lasting 4-12 weeks, though longer-term safety data remains limited.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.